The American Academy of Pediatrics (AAP) announced recommendations for the routine use of influenza vaccine and antiviral medications to prevent and treat influenza in children during the 2021–2022 influenza season.
The AAP stated on September 7, 2021, it recommends annual influenza immunization of all children without medical contraindications, starting at six months of age.
Excerpts from the AAP statement are discussed below:
Updated Recommendations for the Prevention and Control of Influenza in Children
Updated Recommendations for the Prevention and Control of Influenza in Children
The American Academy of Pediatrics (AAP) announced recommendations for the routine use of influenza vaccine and antiviral medications to prevent and treat influenza in children during the 2021–2022 influenza season.
The AAP stated on September 7, 2021, it recommends annual influenza immunization of all children without medical contraindications, starting at six months of age.
Excerpts from the AAP statement are discussed below:
Science Guides the FDA’s COVID-19 Vaccine Decisions for Children
The US Food and Drug Administration (FDA) issued a Statement clarifying lt ‘will follow the science regarding COVID-19 vaccine authorizations for use by young children.’
On September 10, 2021, Dr. Janet Woodcock, Acting Commissioner of FDA, and Peter Marks, M.D., Ph.D., Director – Center for Biologics Evaluation and Research, stated, ‘We know there have been questions and public commentary on the process surrounding vaccines for young children.’
High Viral Load in Lungs Linked to COVID-19 Mortality
No association seen for acquisition of hospital-acquired respiratory pathogen with fatal outcomes for patients with COVID-19
Frequency of Long-Term Symptoms Up With Positive SARS-CoV-2 Test
Persistence of more than four weeks of at least one initially occurring symptom among 76.2 percent of those with positive test
Healthy, Plant-Based Diet Tied to Lower COVID-19 Risk
Association seems to be particularly pronounced among individuals living in areas with higher socioeconomic deprivation
COVAX Cuts Global COVID-19 Vaccine Supply Estimates by a Quarter
United Nations forecast last week that it would have about 25 percent fewer vaccines to distribute through COVAX this year